Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
about
Combating antimicrobial resistance: policy recommendations to save livesWhat is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the ShipAetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).Diagnostic value of procalcitonin and apo-e in extrahepatic biliary atresia.Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?Clinical impact of kidney function on presepsin levels.Procalcitonin Kinetics in the First 72 Hours Predicts 30-Day Mortality in Severely Ill Septic Patients Admitted to an Intermediate Care UnitClinical Value of Procalcitonin in Patients with Spinal Infection.Procalcitonin as diagnostic marker of infection in solid tumors patients with feverProcalcitonin is a strong predictor of urine culture results in patients with obstructing ureteral stones: A prospective, pilot studyThe first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro.Procalcitonin as a biomarker in respiratory tract infection.Early diagnosis of sepsis using serum biomarkers.Serum procalcitonin in the diagnosis and management of intra-abdominal infections.The role of procalcitonin in respiratory infections.Procalcitonin as a biomarker of infectious diseases.Biomarkers for sepsis.The use and value of procalcitonin in solid organ transplantation.Procalcitonin: present and future.Clinical Applications of Procalcitonin in Pediatrics: An Advanced Biomarker for Inflammation and Infection-Can It Also Be Used in Trauma?Emerging infection and sepsis biomarkers: will they change current therapies?Fever in Patients With Cancer.Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.Procalcitonin: The right answer but to which question?Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit.Procalcitonin in diagnosis of post-operative bacterial meningitis: a promising but limited roleUtility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy.Procalcitonin for antibiotic treatment in intensive care unit patients.Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection.Procalcitonin in heart failure: hic et nunc.Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients.Mean platelet volume in patients with increased procalcitonin level.A new sensitive automated assay for procalcitonin detection: LIAISON® BRAHMS PCT® II GEN.Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.
P2860
Q24632857-CC55059C-7E3F-4E6A-A709-9DF8D64EDA75Q26852219-8AE58530-5D99-4C04-B946-05A8BDF2BF6CQ28068503-8C3F5913-BDEA-41C6-9442-EF9D76A9FC57Q30416227-C415B76A-6286-4B64-AB2B-6FCC7C4FF65BQ33889170-7A7C92CB-F3C5-440F-9939-43A2A08DECA8Q34261329-EF4B68B1-A7EB-49CD-9CC6-F3BE9549E4F0Q35176694-6F75F551-A898-412E-B12B-5836833356EBQ35622257-409FAB82-7742-4C3D-A2A7-C5737692FDABQ35648243-975738B2-02E1-470F-969C-39D0F3952334Q35910746-16B82310-8EE1-41EC-AC8C-5C7E854D0598Q36241340-BB9AA99A-2123-4DBD-ABD9-ACA8DED73332Q37014930-327946D2-C6F4-40FB-A172-24C1F9F20355Q37094267-ABF5B9D5-BEED-43AA-A32D-D5B0D51E5ABAQ37661557-6353F3F5-796C-493E-8E49-D305FA530254Q37860806-41C6A4BC-F5CA-453A-84F9-15B3A71028A8Q37894737-9F295422-D357-4279-ACC2-ECF191A55C4EQ37984502-B23EA440-5F37-497E-8FC3-B9BA38FE98A1Q37989831-86DF0740-1D4E-4050-93C7-588EE6E023FDQ38107483-B397610F-B0B7-47D1-8676-936320D76FA4Q38209677-F5211F14-CFDE-4E85-8182-1C6E16DFF5E6Q38495375-105F824A-4D54-40CF-9314-859E5D523689Q38544528-F486F915-4F90-47A9-9F7B-7538D9BF022CQ38880409-F2707DB7-0139-420A-B95D-E44DEED3A360Q38929971-94FE32E4-935F-4CCF-822B-C133CC4D347EQ40059731-92F90AE2-FFD4-4D14-BAB6-4FAB992B67F5Q40132610-E90A166B-F1A0-48AF-AFD4-F68BACB5FE82Q40252197-A67AC26D-737F-4662-B12F-26099FC90DBDQ40345037-EE0D5A20-87AC-4401-8A91-9646CCA043B2Q42851549-80C26DE1-3963-43A8-9BD4-6066784CC979Q43965327-02871721-6ED0-40D9-93A3-9C6F55C89E9BQ45221912-7B003C49-C276-4F4C-9594-532C5FAE07DEQ46478127-D7643208-0639-43B9-8E1C-A077112D54ECQ47102780-5708B070-6083-40AC-A193-6A53F4277D7AQ49613444-CFEEAD9C-1D4D-44A7-A8F3-EAD120A167F6Q52611408-4C52F6EF-BA6F-44DA-B169-1FE76010B7FBQ53374059-9CD47671-1F92-471C-825C-FB0A351669E9Q54569071-53F32AAB-ABF0-4EDA-AA9E-FC3076E0648EQ55022514-388D6D0B-14EF-438D-AB2C-A39E30675BF9
P2860
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
@en
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
@nl
type
label
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
@en
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
@nl
prefLabel
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
@en
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
@nl
P2860
P356
P1476
Use of plasma procalcitonin levels as an adjunct to clinical microbiology.
@en
P2093
David N Gilbert
P2860
P304
P356
10.1128/JCM.00655-10
P407
P577
2010-04-26T00:00:00Z